Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma

Nat Clin Pract Rheumatol. 2007 Dec;3(12):682-3. doi: 10.1038/ncprheum0618. Epub 2007 Sep 11.

Authors

Bent Deleuran¹, David J Abraham

Affiliation

¹ Department of Rheumatology, Aarhus University Hospital, Denmark. b.deleuran@immunology.au.dk

PMID: 17848933
DOI: 10.1038/ncprheum0618

No abstract available

MeSH terms

CD4-Positive T-Lymphocytes / pathology*
CD4-Positive T-Lymphocytes / physiology
Humans
Interleukin-17 / physiology
Interleukin-22
Interleukin-6 / physiology
Interleukins / physiology
Scleroderma, Systemic / immunology*
Scleroderma, Systemic / pathology
Scleroderma, Systemic / physiopathology
T-Lymphocytes, Helper-Inducer / pathology*
T-Lymphocytes, Helper-Inducer / physiology
T-Lymphocytes, Regulatory / pathology
T-Lymphocytes, Regulatory / physiology

Substances

Interleukin-17
Interleukin-6
Interleukins